{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:43:19Z","timestamp":1783968199729,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j intensive care"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Given the conflicting results regarding the clinical outcomes of venoarterial extracorporeal membrane oxygenation (VA-ECMO) based on etiology, its benefit for patients with cardiogenic shock (CS) remains controversial. This study aimed to report the real-world clinical outcomes of VA-ECMO treatment for patients with CS, based on the presence of acute myocardial infarction (AMI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients treated with peripheral VA-ECMO between 2008 and 2023 at a tertiary cardiovascular center were included and classified into two groups based on CS etiology (AMI-CS and non-AMI-CS). Logistic regression models were used to compare in-hospital mortality and to identify prognostic predictors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among the 667 patients included, 264 (39.6%) were classified as having AMI-CS. The rate of cardiac arrest before VA-ECMO initiation was higher in the AMI-CS group than in the non-AMI-CS group (69.7% vs. 55.8%; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Patients in the AMI-CS group were older (66 vs. 61\u00a0years; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), more likely to be male (82.6% vs. 57.3%; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and had a lower left ventricular (LV) ejection fraction (20% vs. 25%; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) than those in the non-AMI-CS group. The AMI-CS group had a lower in-hospital mortality rate (58.6% vs. 69.7%; odds ratio, 0.46; 95% confidence interval, 0.29\u20130.75; <jats:italic>P<\/jats:italic>\u2009=\u20090.002) compared with the non-AMI-CS group. The independent predictors of favorable clinical outcomes after VA-ECMO included younger age, shorter cardiac arrest duration, absence of severe LV dysfunction, absence of renal replacement therapy, higher hemoglobin levels, higher arterial pH, and lower lactate levels. The association between in-hospital mortality and AMI-CS was also demonstrated in the propensity score matching analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In this single-center study, AMI-CS was associated with a lower in-hospital mortality than non-AMI-CS after VA-ECMO treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s40560-025-00807-w","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:27:57Z","timestamp":1751448477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic implication of venoarterial extracorporeal membrane oxygenation in acute myocardial infarction-related cardiogenic shock"],"prefix":"10.1186","volume":"13","author":[{"given":"Jonghu","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Mi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minju","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Jin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Keuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Guk","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong-Ki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangsoo","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"9","key":"807_CR1","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"SS Naidu","year":"2022","unstructured":"Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol. 2022;79(9):933\u201346.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"807_CR2","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"H Thiele","year":"2012","unstructured":"Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287\u201396.","journal-title":"N Engl J Med"},{"issue":"25","key":"807_CR3","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","volume":"377","author":"H Thiele","year":"2017","unstructured":"Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377(25):2419\u201332.","journal-title":"N Engl J Med"},{"issue":"3","key":"807_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032288","volume":"13","author":"JC Jentzer","year":"2024","unstructured":"Jentzer JC, Drakos SG, Selzman CH, Owyang C, Teran F, Tonna JE. Timing of initiation of extracorporeal membrane oxygenation support and outcomes among patients with cardiogenic shock. J Am Heart Assoc. 2024;13(3): e032288.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"807_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jacc.2018.11.038","volume":"73","author":"M Guglin","year":"2019","unstructured":"Guglin M, Zucker MJ, Bazan VM, Bozkurt B, El Banayosy A, Estep JD, et al. Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol. 2019;73(6):698\u2013716.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"807_CR6","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/CIR.0000000000001076","volume":"146","author":"BJ Geller","year":"2022","unstructured":"Geller BJ, Sinha SS, Kapur NK, Bakitas M, Balsam LB, Chikwe J, et al. Escalating and de-escalating temporary mechanical circulatory support in cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2022;146(6):e50\u201368.","journal-title":"Circulation"},{"issue":"36","key":"807_CR7","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"18","key":"807_CR8","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"issue":"10","key":"807_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/ehjacc\/zuae098","volume":"13","author":"DD Berg","year":"2024","unstructured":"Berg DD, Bohula EA, Patel SM, Alfonso CE, Alviar CL, Baird-Zars VM, et al. Epidemiology of cardiogenic shock using the Shock Academic Research Consortium (SHARC) consensus definitions. Eur Heart J Acute Cardiovasc Care. 2024;13(10):709\u201314.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"4","key":"807_CR10","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1002\/ehf2.13481","volume":"8","author":"SW Seong","year":"2021","unstructured":"Seong SW, Jin G, Kim M, Ahn KT, Yang JH, Gwon HC, et al. Comparison of in-hospital outcomes of patients with vs. without ischaemic cardiomyopathy undergoing veno-arterial-extracorporeal membrane oxygenation. ESC Heart Fail. 2021;8(4):3308\u201315.","journal-title":"ESC Heart Fail"},{"issue":"6","key":"807_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.009279","volume":"15","author":"SS Sinha","year":"2022","unstructured":"Sinha SS, Rosner CM, Tehrani BN, Maini A, Truesdell AG, Lee SB, et al. Cardiogenic shock from heart failure versus acute myocardial infarction: clinical characteristics, hospital course, and 1-year outcomes. Circ Heart Fail. 2022;15(6): e009279.","journal-title":"Circ Heart Fail"},{"issue":"6","key":"807_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.4244\/EIJ-D-23-00204","volume":"19","author":"AS Banning","year":"2023","unstructured":"Banning AS, Sabat\u00e9 M, Orban M, Gracey J, L\u00f3pez-Sobrino T, Massberg S, et al. Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial. EuroIntervention. 2023;19(6):482\u201392.","journal-title":"EuroIntervention"},{"issue":"14","key":"807_CR13","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","volume":"389","author":"H Thiele","year":"2023","unstructured":"Thiele H, Zeymer U, Akin I, Behnes M, Rassaf T, Mahabadi AA, et al. Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med. 2023;389(14):1286\u201397.","journal-title":"N Engl J Med"},{"issue":"14","key":"807_CR14","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.123.064527","volume":"148","author":"R Waksman","year":"2023","unstructured":"Waksman R, Pahuja M, van Diepen S, Proudfoot AG, Morrow D, Spitzer E, et al. Standardized definitions for cardiogenic shock research and mechanical circulatory support devices: scientific expert panel from the Shock Academic Research Consortium (SHARC). Circulation. 2023;148(14):1113\u201326.","journal-title":"Circulation"},{"issue":"18","key":"807_CR15","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"807_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/MAT.0000000000001510","volume":"67","author":"R Lorusso","year":"2021","unstructured":"Lorusso R, Shekar K, MacLaren G, Schmidt M, Pellegrino V, Meyns B, et al. ELSO interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients. ASAIO J. 2021;67(8):827\u201344.","journal-title":"ASAIO J"},{"issue":"1","key":"807_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/MAT.0000000000000475","volume":"63","author":"RR Thiagarajan","year":"2017","unstructured":"Thiagarajan RR, Barbaro RP, Rycus PT, McMullan DM, Conrad SA, Fortenberry JD, et al. Extracorporeal life support organization registry international report 2016. ASAIO J. 2017;63(1):60\u20137.","journal-title":"ASAIO J"},{"key":"807_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.116.004337","author":"A Mandawat","year":"2017","unstructured":"Mandawat A, Rao SV. Percutaneous mechanical circulatory support devices in cardiogenic shock. Circ Cardiovasc Interv. 2017. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.116.004337.","journal-title":"Circ Cardiovasc Interv"},{"issue":"13","key":"807_CR19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1161\/CIRCULATIONAHA.123.067087","volume":"149","author":"E L\u00fcsebrink","year":"2024","unstructured":"L\u00fcsebrink E, Binzenh\u00f6fer L, Hering D, Villegas Sierra L, Schrage B, Scherer C, et al. Scrutinizing the role of venoarterial extracorporeal membrane oxygenation: has clinical practice outpaced the evidence? Circulation. 2024;149(13):1033\u201352.","journal-title":"Circulation"},{"issue":"14","key":"807_CR20","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.jacc.2023.07.019","volume":"82","author":"RJ Tedford","year":"2023","unstructured":"Tedford RJ, Leacche M, Lorts A, Drakos SG, Pagani FD, Cowger J. Durable mechanical circulatory support: JACC scientific statement. J Am Coll Cardiol. 2023;82(14):1464\u201381.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"807_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","volume":"147","author":"P Ostadal","year":"2023","unstructured":"Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, et al. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation. 2023;147(6):454\u201364.","journal-title":"Circulation"},{"issue":"3","key":"807_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jcin.2021.11.036","volume":"15","author":"M Megaly","year":"2022","unstructured":"Megaly M, Buda K, Alaswad K, Brilakis ES, Dupont A, Naidu S, et al. Comparative analysis of patient characteristics in cardiogenic shock studies: differences between trials and registries. JACC Cardiovasc Interv. 2022;15(3):297\u2013304.","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"807_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40560-021-00571-7","volume":"9","author":"IH Park","year":"2021","unstructured":"Park IH, Yang JH, Jang WJ, Chun WJ, Oh JH, Park YH, et al. Clinical significance of lactate clearance in patients with cardiogenic shock: results from the RESCUE registry. J Intensive Care. 2021;9(1):63.","journal-title":"J Intensive Care"},{"issue":"2","key":"807_CR24","volume":"2","author":"JC Jentzer","year":"2023","unstructured":"Jentzer JC, Naidu SS, Bhatt DL, Stone GW. Mechanical circulatory support devices in acute myocardial infarction-cardiogenic shock: current studies and future directions. J Soc Cardiovasc Angiogr Interv. 2023;2(2): 100586.","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"3","key":"807_CR25","first-page":"e18","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):e18\u2013114.","journal-title":"Circulation"},{"issue":"38","key":"807_CR26","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720\u2013826.","journal-title":"Eur Heart J"},{"issue":"1","key":"807_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40560-024-00770-y","volume":"13","author":"R Sato","year":"2025","unstructured":"Sato R, Hasegawa D, Guo S, Nuqali AE, Moreno JEP. Sepsis-induced cardiogenic shock: controversies and evidence gaps in diagnosis and management. J Intensive Care. 2025;13(1):1.","journal-title":"J Intensive Care"},{"issue":"2","key":"807_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrcardio.2017.139","volume":"15","author":"GH Kim","year":"2018","unstructured":"Kim GH, Uriel N, Burkhoff D. Reverse remodelling and myocardial recovery in heart failure. Nat Rev Cardiol. 2018;15(2):83\u201396.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"807_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jacc.2020.11.043","volume":"77","author":"AA Harhash","year":"2021","unstructured":"Harhash AA, May TL, Hsu CH, Agarwal S, Seder DB, Mooney MR, et al. Risk stratification among survivors of cardiac arrest considered for coronary angiography. J Am Coll Cardiol. 2021;77(4):360\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"807_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.008141","volume":"14","author":"JH Yang","year":"2021","unstructured":"Yang JH, Choi KH, Ko Y-G, Ahn C-M, Yu CW, Chun WJ, et al. Clinical characteristics and predictors of in-hospital mortality in patients with cardiogenic shock: results from the RESCUE registry. Circ Heart Fail. 2021;14(6): e008141.","journal-title":"Circ Heart Fail"},{"issue":"5","key":"807_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ejhf.260","volume":"17","author":"VP Harjola","year":"2015","unstructured":"Harjola VP, Lassus J, Sionis A, Kober L, Tarvasmaki T, Spinar J, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17(5):501\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"807_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00392-023-02332-y","volume":"113","author":"J Sundermeyer","year":"2024","unstructured":"Sundermeyer J, Kellner C, Beer BN, Besch L, Dettling A, Bertoldi LF, et al. Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock. Clin Res Cardiol. 2024;113(4):570\u201380.","journal-title":"Clin Res Cardiol"}],"container-title":["Journal of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-025-00807-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40560-025-00807-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-025-00807-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:27:58Z","timestamp":1751448478000},"score":1,"resource":{"primary":{"URL":"https:\/\/jintensivecare.biomedcentral.com\/articles\/10.1186\/s40560-025-00807-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1186\/s40560-025-00807-w","relation":{},"ISSN":["2052-0492"],"issn-type":[{"value":"2052-0492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of Yonsei University and was performed in accordance with the Declaration of Helsinki. The requirement for informed consent was waived due to the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"38"}}